MatthewRubenstein (Matt)

Associate

Minneapolis + 1.612.217.8846

Matt Rubenstein's practice focuses on appellate advocacy and complex litigation. His work has spanned a range of substantive areas including securities regulation, criminal law, and bankruptcy. He has worked on briefs submitted to the U.S Supreme Court; federal bankruptcy, district, and circuit courts; the SEC; and state intermediate and high courts.

Experience

  • Sloan Kettering and Juno Therapeutics win over $1.1 billion after jury verdict and post-trial motions in patent dispute with Kite Pharma/Gilead involving CAR-T therapyOn behalf of patentee Sloan Kettering Institute and exclusive licensee Juno Therapeutics (a subsidiary of Celgene Corporation, a Bristol Myers Squibb company), Jones Day and co-counsel prevailed in a jury trial that spanned eight days and involved 22 witnesses, winning $752 million for infringement by Kite Pharma, Inc. (a Gilead Sciences, Inc. company) in the making and selling of its CAR-T therapy, YESCARTA®.
  • Legal scholars file amicus brief in Second Circuit in support of sexual assault victim at military academyJones Day filed an amicus brief on behalf of a group of legal scholars to assist the Second Circuit as it considered whether a cadet at the United States Military Academy at West Point could bring claims under the Federal Torts Claims Act for the rape and sexual harassment she endured.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.